beta-D-Galp-(1->2)-[beta-D-Galp-(1->3)]-alpha-L-Fucp

Term ID

CHEBI:149411

Synonyms

(2S,3R,4S,5R,6R)-2-[(2R,3S,4R,5R,6S)-2,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-galacto-hexopyranosyl-(1->2)-[beta-D-galacto-hexopyranosyl-(1->3)]-6-deoxy-alpha-L-galacto-hexopyranose
beta-D-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)]-6-deoxy-alpha-L-galactopyranose
beta-D-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)]-alpha-L-fucopyranose
Gal(b1-2)[Gal(b1-3)]a-Fuc

Definition

A trisaccharide that is α-L-fucopyranose in which the hydroxy groups at positions 2 and 3 have each been converted into the corresponding β-D-galactopyranosyl derivative.

References

glygen:G34122OI
glytoucan:G34122OI

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->2)-[beta-D-Galp-(1->3)]-alpha-L-Fucp

Phenotype where environments contain beta-D-Galp-(1->2)-[beta-D-Galp-(1->3)]-alpha-L-Fucp

Phenotype modified by environments containing beta-D-Galp-(1->2)-[beta-D-Galp-(1->3)]-alpha-L-Fucp

Phenotype affecting beta-D-Galp-(1->2)-[beta-D-Galp-(1->3)]-alpha-L-Fucp

Human Disease Model